Operating Income (Loss) in USD of Kraig Biocraft Laboratories, Inc from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kraig Biocraft Laboratories, Inc quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Kraig Biocraft Laboratories, Inc Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$1.43M, a 238% decline year-over-year.
  • Kraig Biocraft Laboratories, Inc Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$3.37M, a 5.04% increase year-over-year.
  • Kraig Biocraft Laboratories, Inc annual Operating Income (Loss) for 2024 was -$3.07M, a 17.6% decline from 2023.
  • Kraig Biocraft Laboratories, Inc annual Operating Income (Loss) for 2023 was -$2.61M, a 23.3% decline from 2022.
  • Kraig Biocraft Laboratories, Inc annual Operating Income (Loss) for 2022 was -$2.12M, a 23.1% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Kraig Biocraft Laboratories, Inc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3.37M -$1.43M -$1.01M -238% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$2.36M -$638K +$848K +57.1% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$3.21M -$580K -$132K -29.4% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$3.07M -$716K +$472K +39.7% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025
Q3 2024 -$3.55M -$424K +$35.6K +7.76% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$3.58M -$1.49M -$1.01M -209% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$2.58M -$449K +$37.9K +7.78% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$2.61M -$1.19M -$674K -131% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025
Q3 2023 -$1.94M -$459K +$65.8K +12.5% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$2.01M -$481K +$56K +10.4% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$2.06M -$487K +$59.1K +10.8% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$2.12M -$514K +$3.14K +0.61% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$2.12M -$525K +$347K +39.8% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$2.47M -$537K +$169K +23.9% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$2.64M -$546K +$119K +17.9% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$2.76M -$517K -$16.1K -3.22% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 -$2.74M -$873K -$274K -45.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$2.47M -$705K -$235K -49.9% 01 Apr 2021 30 Jun 2021 10-Q 01 Aug 2022
Q1 2021 -$2.23M -$665K +$2.3M +77.6% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$4.53M -$501K +$317K +38.8% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 -$4.85M -$598K +$458K +43.4% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 -$5.31M -$470K -$135K -40.3% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$5.17M -$2.96M -$2.55M -620% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 -$2.62M -$818K -$385K -89.1% 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 -$2.24M -$1.06M -$909K -614% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$1.33M -$335K -$182K -119% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020
Q1 2019 -$1.15M -$412K -$185K -81.9% 01 Jan 2019 31 Mar 2019 10-Q 21 Apr 2020
Q4 2018 -$960K -$433K -$181K -72.3% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 -$779K -$148K +$86.5K +36.9% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$865K -$153K +$1.06M +87.4% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 -$1.93M -$227K +$228K +50.1% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$2.16M -$251K +$627K +71.4% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$2.78M -$234K +$855K +78.5% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 -$3.64M -$1.22M -$715K -143% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$2.92M -$454K +$23.5K +4.91% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 -$2.95M -$878K -$494K -128% 01 Oct 2016 31 Dec 2016 10-K 23 Mar 2018
Q3 2016 -$2.45M -$1.09M -$766K -237% 01 Jul 2016 30 Sep 2016 10-Q 15 Nov 2017
Q2 2016 -$1.69M -$501K +$443K +46.9% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$2.13M -$478K -$74K -18.3% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$2.05M -$384K +$30K +7.24% 01 Oct 2015 31 Dec 2015 10-K 22 Mar 2017
Q3 2015 -$2.08M -$323K -$101K -45.4% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$1.98M -$943K -$398K -72.9% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 -$1.59M -$404K +$248K +38.1% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$1.83M -$414K +$315K +43.2% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$2.15M -$222K +$719K +76.4% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 -$2.87M -$546K -$260K -91.1% 01 Apr 2014 30 Jun 2014 10-Q 11 Aug 2015
Q1 2014 -$2.61M -$652K -$394K -152% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$2.21M -$730K -$86.1K -13.4% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$2.13M -$941K -$664K -240% 01 Jul 2013 30 Sep 2013 10-Q 23 Oct 2014
Q2 2013 -$1.46M -$286K +$216K +43.1% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$1.68M -$259K -$121K -87.3% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$1.56M -$644K -$240K -59.5% 01 Oct 2012 31 Dec 2012 10-K 15 Apr 2014
Q3 2012 -$1.32M -$277K +$48.3K +14.8% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2013
Q2 2012 -$1.37M -$502K -$164K -48.6% 01 Apr 2012 30 Jun 2012 10-Q/A 31 Dec 2013
Q1 2012 -$1.2M -$138K +$92.9K +40.2% 01 Jan 2012 31 Mar 2012 10-Q/A 24 Dec 2013
Q4 2011 -$1.3M -$403K 01 Oct 2011 31 Dec 2011 10-K/A 24 Dec 2013
Q3 2011 -$325K +$261K +44.6% 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012
Q2 2011 -$338K -$207K -159% 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012
Q1 2011 -$231K 01 Jan 2011 31 Mar 2011 10-Q 21 May 2012
Q3 2010 -$587K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$130K 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

Kraig Biocraft Laboratories, Inc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3.07M -$460K -17.6% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$2.61M -$493K -23.3% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 -$2.12M +$638K +23.1% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$2.76M +$1.77M +39.1% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 -$4.53M -$1.91M -72.9% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$2.62M -$1.66M -173% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021
2018 -$960K +$1.2M +55.5% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 -$2.16M +$790K +26.8% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$2.95M -$891K -43.4% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018
2015 -$2.05M -$220K -12% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017
2014 -$1.83M +$381K +17.2% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$2.21M -$654K -41.9% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$1.56M -$263K -20.3% 01 Jan 2012 31 Dec 2012 10-K 15 Apr 2014
2011 -$1.3M -$11K -0.85% 01 Jan 2011 31 Dec 2011 10-K/A 24 Dec 2013
2010 -$1.29M 01 Jan 2010 31 Dec 2010 10-K 12 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.